open access

Vol 85, No 8 (2014)
ARTICLES
Get Citation

Intravaginal misoprostol alone versus intravaginal misoprostol and extraamniotic Foley catheter for second trimester pregnancy termination: an observational study

Tayfun Toptas, Inanc Mendilcioglu, Mehmet Simsek, Omur Taskin
DOI: 10.17772/gp/1774
·
Ginekol Pol 2014;85(8).

open access

Vol 85, No 8 (2014)
ARTICLES

Abstract

Background: No systematic empirical research exists addressing the question of optimal pregnancy termination method in second trimester pregnancies. Objectives: The purpose of this study was to determine the efficacy and safety of intravaginal misoprostol and extraamniotic Foley catheter combination for second trimester pregnancy termination. Methods: A single center, observational study was conducted in a total of 91 pregnancies. Women who met the termination of pregnancy criteria due to feto-maternal indications between 13 to 26 gestational weeks were included into the study. Study participants received intravaginal misoprostol in combination with Foley catheter (n=46) or intravaginal misoprostol alone (n=45). Results: The efficacy of intravaginal misoprostol and Foley catheter insertion combination was comparable to that of intravaginal misoprostol alone in terms of time to abortion/birth [median (95% Confidential Interval [95% CI]): 14.33 (11.33-17.25) hours and 12.08 (9.50-15.33) hours, respectively. Hazard Ratio: 0.73, 95% CI: 0.47 to 1.12, p= 0.14 (log-rank)]. The only serious maternal event was uterine rupture observed in one woman in Foley combination group. Conclusion: The combination of intravaginal misoprostol and extraamniotic Foley catheter for second trimester pregnancy termination does not provide additional efficacy.

Abstract

Background: No systematic empirical research exists addressing the question of optimal pregnancy termination method in second trimester pregnancies. Objectives: The purpose of this study was to determine the efficacy and safety of intravaginal misoprostol and extraamniotic Foley catheter combination for second trimester pregnancy termination. Methods: A single center, observational study was conducted in a total of 91 pregnancies. Women who met the termination of pregnancy criteria due to feto-maternal indications between 13 to 26 gestational weeks were included into the study. Study participants received intravaginal misoprostol in combination with Foley catheter (n=46) or intravaginal misoprostol alone (n=45). Results: The efficacy of intravaginal misoprostol and Foley catheter insertion combination was comparable to that of intravaginal misoprostol alone in terms of time to abortion/birth [median (95% Confidential Interval [95% CI]): 14.33 (11.33-17.25) hours and 12.08 (9.50-15.33) hours, respectively. Hazard Ratio: 0.73, 95% CI: 0.47 to 1.12, p= 0.14 (log-rank)]. The only serious maternal event was uterine rupture observed in one woman in Foley combination group. Conclusion: The combination of intravaginal misoprostol and extraamniotic Foley catheter for second trimester pregnancy termination does not provide additional efficacy.
Get Citation

Keywords

Foley catheterization, prostaglandins, abortion, induced, pregnancy, second trimester, misoprostol

About this article
Title

Intravaginal misoprostol alone versus intravaginal misoprostol and extraamniotic Foley catheter for second trimester pregnancy termination: an observational study

Journal

Ginekologia Polska

Issue

Vol 85, No 8 (2014)

DOI

10.17772/gp/1774

Bibliographic record

Ginekol Pol 2014;85(8).

Keywords

Foley catheterization
prostaglandins
abortion
induced
pregnancy
second trimester
misoprostol

Authors

Tayfun Toptas
Inanc Mendilcioglu
Mehmet Simsek
Omur Taskin

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl